LONDON, NEW YORK — December 10, 2014 — OpenGamma, a leading provider of OTC market structure risk management and analytics solutions, has won “Best New Product” in the collateral management category of the 2014 FOW International Awards for its product, The OpenGamma Platform for Margining.
The FOW International Awards, sponsored by the Futures and Options World, recognize achievements and innovations by leading technologies and third-party vendors in the derivatives industry.
“The constant ability to manage clients and house funding, liquidity risk and assess in near real-time any margin requirements and calculations is a vital step in enabling clearing and trading businesses’ in the new regulatory world,” said one judge of the platform.
The OpenGamma Platform for Margining enables firms to optimize their businesses in the evolving OTC markets, improving capital efficiency and balance sheet management. It provides tools for multi-CCP (central counterparty) margin calculations, what-if analysis and stress testing.
OpenGamma added the OpenGamma Platform for Margining to its product line in November 2013, to complement its existing open-source market risk platform.
“The OTC regulatory evolution is still a fluid process, and one that will challenge market participants’ ability to adapt swiftly,” said Mas Nakachi, CEO of OpenGamma. “We are honored to have been selected as the ‘Best New Product’ for collateral management by the FOW. This award is illustrative of OpenGamma’s growing role at the heart of margin calculations in the market structure evolution.”
Since the release of the OpenGamma Platform for Margining, OpenGamma has claimed “Best Market Risk Product” at the Sell-Side Technology Awards, and places in the prestigious Institutional Investor Tech 50 and Financial News FinTech 40.
The winners of the FOW Awards were announced during an awards dinner in London on December 9.
OpenGamma helps financial services firms evaluate, understand, and manage market risk in an open, transparent manner.
The OpenGamma Platform enables firms to optimize their businesses in the evolving OTC markets, improving capital efficiency and balance sheet management. It provides tools for multi-CCP margin calculations, what-if analysis and stress testing, and real-time, cross-asset risk and trading analytics across customized risk scenarios and industry-standard metrics.
Used by both buy-side and sell-side firms, exchanges, CCPs, and other segments of the OTC derivatives market structure, OpenGamma brings a new standard of transparency to the industry, enabling users to gain more insight into their underlying risk exposures, better assess the true costs of trading, and respond more rapidly to the ever-evolving regulatory landscape.
Backed by Accel Partners, FirstMark Capital, ICAP plc and Euclid Opportunities, OpenGamma is headquartered in London with an office in New York. For more information, visit https://opengamma.com.
Paragon Public Relations LLC